2'-Fluoro-2'-deoxycytidine

2'-Deoxy-2'-fluorocytidine can synergize with T705 to enhance the antiviral efficacy of both compounds against CCHFV replication, and is widely used in the development of antiviral bioactive molecules and drug molecules. Firstly, it has garnered significant attention as an effective inhibitor of Crimean-Congo hemorrhagic fever virus (CCHFV) replication. CCHFV is a tick-borne virus that can cause severe hemorrhagic fever symptoms. By inhibiting the viral replication process, 2'-deoxy-2'-fluorocytidine can reduce the proliferation of the virus in host cells, thereby offering potential therapeutic value for viral treatment. This inhibitor can serve as a reference in drug development for creating more effective antiviral drugs against CCHFV.